Maternal Asthma Management and Perinatal Outcomes

Summary

Asthma is one of the most common chronic conditions encountered in pregnancy, affecting up to 10% of expectant mothers globally. Physiological changes in airway responsiveness, hormonal shifts and immunological adaptations can alter disease control, with up to one-third of women experiencing worsening symptoms. Poorly controlled asthma increases the risk of pre-eclampsia, preterm birth, intrauterine growth restriction, low birth weight and perinatal mortality. Optimal management centres on maintenance of baseline control through personalised treatment plans, adherence to inhaled corticosteroids and avoidance of precipitants. Emerging strategies incorporate biomarkers such as fractional exhaled nitric oxide to tailor anti-inflammatory therapy, while biologic agents are under evaluation for severe, refractory disease. Effective multidisciplinary care, involving obstetricians, respiratory physicians and primary care teams, is essential to safeguard both maternal health and fetal development.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Maternal Asthma Management and Perinatal Outcomes publication trend

The graph below shows the total number of articles in maternal asthma management and perinatal outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Fractional exhaled nitric oxide (FeNO): A non-invasive marker of eosinophilic airway inflammation used to guide inhaled corticosteroid dosing.

Inhaled corticosteroids (ICS): Anti-inflammatory medications delivered by inhalation to control chronic airway inflammation in asthma.

Exacerbation: An acute or subacute worsening of asthma symptoms requiring increased medication or healthcare intervention.

Preterm birth: Delivery before 37 completed weeks of gestation, associated with increased neonatal morbidity and mortality.

Small for gestational age (SGA): A birth weight below the 10th percentile for the gestational age, indicating restricted fetal growth.

References

  1. Investigations on incidence and relevant factors of allergies in 5725 urban pregnant women: a cohort study in China. BMC Public Health (2023).
  2. Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort. Journal of Allergy and Clinical Immunology (2019).
  3. Asthma during Pregnancy in a Population-Based Study - Pregnancy Complications and Adverse Perinatal Outcomes. PLOS ONE (2014).
  4. The Breathing for Life Trial: a randomised controlled trial of fractional exhaled nitric oxide (FENO)-based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health. BMC Pregnancy and Childbirth (2016).
  5. Asthma in Pregnancy: Pathophysiology, Diagnosis, Whole‐Course Management, and Medication Safety. Canadian Respiratory Journal (2020).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.